Former pro soccer players show brain changes but no cognitive decline, researchers find
Britain gets experimental drug from Japan to bolster hantavirus response
US-UK pharma deal: Britain’s biggest company AstraZeneca to invest $405 million in Britain
Sanofi's genetic disorder drug shows mixed results in late-stage trials